Cargando…
Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients
BACKGROUND: Hypertension (HTN) is the most prevalent non-infectious disease worldwide and can lead to mortality. This trial aimed to compare the effect of N-acetylcysteine (NAC) and angiotensin-converting enzyme inhibitors (ACEIs) on controlling blood pressure in hypertensive patients. METHODS: This...
Autores principales: | Khaledifar, Arsalan, Mobasheri, Mahmoud, Kheiri, Soleiman, Zamani, Zeinab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460347/ https://www.ncbi.nlm.nih.gov/pubmed/26089925 |
Ejemplares similares
-
Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
por: Khaledifar, Arsalan, et al.
Publicado: (2015) -
Once- Versus Twice-Daily Angiotensin-Converting Enzyme Inhibitors for Blood Pressure Control in Adult Patients With Hypertension
por: Fischer, Kyle, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?
por: Turner, Jeffrey M., et al.
Publicado: (2020) -
Aliskiren – an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension
por: Zaporowska-Stachowiak, Iwona, et al.
Publicado: (2013)